Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

FDA approves Aklief cream for topical treatment of acne

Oct. 7, 2019

Shire Human Genetic Therapies presents new kallikrein B inhibitors

Oct. 7, 2019

Cabaletta Bio receives FDA IND clearance to initiate first-in-human study of DSG3-CAART

Oct. 2, 2019

AnaptysBio reports phase II interim data on ANB-019 in generalized pustular psoriasis

Oct. 1, 2019

Pfizer announces topline results from pivotal JADE MONO-2 study of abrocitinib

Sep. 30, 2019

First patient dosed in phase III TRuE-V clinical trial program of ruxolitinib cream

Sep. 26, 2019

Galapagos initiates phase I trial with GLPG-3970

Sep. 26, 2019

Phase III study of StrataGraft regenerative tissue meets both primary endpoints

Sep. 25, 2019

Bristol-Myers Squibb designs RORgammaT inverse agonists showing biologic-like efficacy

Sep. 9, 2019

Krystal Biotech initiates phase I/II study of topical KB-105 gene therapy for TGM1-deficient ARCI

Sep. 2, 2019

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...